DEA Extends COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for 6 Months
HIT Consultant
MAY 9, 2023
Background On March 1, 2023, DEA, in concert with HHS, issued notices of proposed rulemakings (NPRM) to allow for prescribing of certain controlled medications via telemedicine without an in-person medical evaluation of the patient under circumstances that are consistent with public health, safety, and effective controls against diversion.
Let's personalize your content